We have a bold ambition: to stop prostate cancer limiting men's lives. And it’s through funding research that we will make this happen.
This goal is underpinned by our research strategy, which sets out how we invest in the most innovative ideas to accelerate improvements for men. Specifically, we focus on funding research in three key areas: better diagnosis, better treatments and smarter data. By tackling these areas, we can make the biggest impact to men with, or at risk of, prostate cancer.
Our research is at risk
Help make sure our progress is not lost
The coronavirus pandemic is having a huge impact on every aspect of life. For many, this impact will be temporary. But for men living with or after prostate cancer in the UK, this crisis could have a devastating long-term consequence: by putting life-saving prostate cancer research at risk.
Research is crucial to finding new ways to treat and diagnose prostate cancer, and ensure no fathers, sons, brothers and friends are lost to this terrible disease. But for months, prostate cancer labs across the UK were closed due to the physical distancing measures required to contain the virus, and research came to a halt. Without urgent funds, there’s a real risk that much of this ground-breaking work may never re-start.
No one knows exactly when we will emerge from this crisis, but when we do, it’s critical we give our researchers the time and resources they need to resume their life-saving work.
To find out about other ways you can help get research back on track and support men, click here.
Research Innovation Awards: Focus on advanced disease as we invest £2.8m
From a pioneering new drug about to hit clinical trials, to a revolutionary home urine test for prostate cancer, here's the projects we're funding in this round of Research Innovation Awards.
After ten years working on a new treatment for men, this researcher is at a critical point
Simon Mackay's innovative new drug needs an extra push so it can be tested in clinical trials.
As prostate cancer deaths hit all-time high, we renew our MANifesto
Today we renew our MANifesto and call for fresh support for our movement in response to new data showing prostate cancer deaths hit a record high of 12,000 in one year.